Integra Lifesciences Holdings Stock Investor Sentiment

IART Stock  USD 28.68  2.95  9.33%   
Slightly above 58% of Integra LifeSciences' investor base is looking to short. The analysis of overall sentiment of trading Integra LifeSciences Holdings stock suggests that many investors are alarmed at this time. Integra LifeSciences' investor sentiment overview provides quick insight into current market opportunities from investing in Integra LifeSciences Holdings. The current market sentiment, together with Integra LifeSciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Integra LifeSciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

42

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Integra LifeSciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Integra LifeSciences Holdings.
Integra LifeSciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Integra daily returns and investor perception about the current price of Integra LifeSciences Holdings as well as its diversification or hedging effects on your existing portfolios.

Integra Historical Sentiment

Although Integra LifeSciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Integra, such as negative comments on social media and news outlets, may cause fear in the market and push Integra LifeSciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Integra.
  

Integra LifeSciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Integra LifeSciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Integra LifeSciences Historical Investor Sentiment

Investor biases related to Integra LifeSciences' public news can be used to forecast risks associated with an investment in Integra. The trend in average sentiment can be used to explain how an investor holding Integra can time the market purely based on public headlines and social activities around Integra LifeSciences Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Integra LifeSciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Integra LifeSciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Integra LifeSciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Integra LifeSciences.
few days ago at www.macroaxis.com         
Disposition of 223 shares by Jeffrey Mosebrook of Integra LifeSciences at 35.88 subject to Rule 16b-...
Macroaxis News
few days ago at businesswire.com         
Toshiba celebra el Da de la Tierra a lo largo de todo el ao
businesswire News
few days ago at globenewswire.com         
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6...
Macroaxis News: globenewswire.com
few days ago at finance.yahoo.com         
Edwards Lifesciences Earnings Expected to Grow What to Know Ahead of Next Weeks Release
Yahoo News
few days ago at zacks.com         
Earnings Preview Integra LifeSciences Q1 Earnings Expected to Decline
zacks News
few days ago at finance.yahoo.com         
Earnings Preview Integra LifeSciences Q1 Earnings Expected to Decline
Yahoo News
six days ago at finance.yahoo.com         
Qlik Sets the Pace for Real-World AI Business Transformations Across Industries
Yahoo News
over a week ago at news.google.com         
Integra LifeSciences Hits New 52-Week Low at 33.12 - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
State of Alaska Department of Revenue Has 922000 Stock Holdings in Integra LifeSciences Holdings Co....
Google News at Macroaxis
over a week ago at autoblog.com         
2025 Acura MDX ditches touchpad, embraces touchscreens, Google, Bang Olufsen
news
over a week ago at autoblog.com         
2025 Acura ADX teased as the new entry-level crossover
news
over two weeks ago at news.google.com         
Integra LifeSciences Holdings Co. Shares Sold by State of Michigan Retirement System - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Integra LifeSciences Holdings Co. to Post FY2024 Earnings of 3.17 Per Share, Zacks Research ... - Ma...
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Lea Knight of 27308 shares of Integra LifeSciences at 36.22 subject to Rule 16b-3
Macroaxis News
over two weeks ago at carscoops.com         
Acura Interga Plummets 16 percent While Honda Civic Sales Surges 36 Percent In Q1
news
Far too much social signal, news, headlines, and media speculation about Integra LifeSciences that are available to investors today. That information is available publicly through Integra media outlets and privately through word of mouth or via Integra internal channels. However, regardless of the origin, that massive amount of Integra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Integra LifeSciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Integra LifeSciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Integra LifeSciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Integra LifeSciences alpha.

Integra LifeSciences Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Integra Lifesciences Holdings Corp Investor Day Transcript
03/05/2024
2
Acquisition by Singh Harvinder of 1179 shares of Integra LifeSciences subject to Rule 16b-3
03/08/2024
3
Turkish Broker Integra Licenses CyberCube Software to Bolster Cyber Growth
03/25/2024
4
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
04/01/2024
5
Integra LifeSciences completes acquisition of JJs Acclarent
04/02/2024
6
Citi upgrades Integra LifeSciences stock, sees challenges as priced in
04/03/2024
7
Acquisition by Lea Knight of 27308 shares of Integra LifeSciences at 36.22 subject to Rule 16b-3
04/05/2024
8
2025 Acura MDX ditches touchpad, embraces touchscreens, Google, Bang Olufsen
04/09/2024
9
Qlik Sets the Pace for Real-World AI Business Transformations Across Industries
04/16/2024
10
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
04/18/2024
11
Disposition of 223 shares by Jeffrey Mosebrook of Integra LifeSciences at 35.88 subject to Rule 16b-3
04/19/2024
When determining whether Integra LifeSciences is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Integra Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Integra Lifesciences Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Integra Lifesciences Holdings Stock:

Complementary Tools for Integra Stock analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.60)
Earnings Share
0.84
Revenue Per Share
19.248
Quarterly Revenue Growth
(0)
Return On Assets
0.0424
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.